Emmanuelle Meuillet

  • 2232 Citations
  • 26 h-Index
1993 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Emmanuelle Meuillet is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Neoplasms Medicine & Life Sciences
Gangliosides Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Cells Chemical Compounds
Phosphatidylinositol 3-Kinase Medicine & Life Sciences
Tumors Chemical Compounds
Lipids Medicine & Life Sciences
Cell Line Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2001 2016

Thioredoxins
Neoplasms
Oxidation-Reduction
Cell Death
Phosphatidylinositol 3-Kinase
Prostaglandins
Dinoprostone
Colonic Neoplasms
Neoplasms
Cyclooxygenase 2 Inhibitors
Skin Neoplasms
Skin
Carcinogenesis
Ultraviolet Rays
Neoplasms
Oxidation-Reduction
Thioredoxins
Selenium
Neoplasms
Proteins

Research Output 1993 2019

  • 2232 Citations
  • 26 h-Index
  • 55 Article
  • 1 Chapter
  • 1 Comment/debate
  • 1 Review article

An inhibitor of the pleckstrin homology domain of CNK1 selectively blocks the growth of mutant KRAS cells and tumors

Indarte, M., Puentes, R., Maruggi, M., Ihle, N. T., Grandjean, G., Scott, M., Ahmed, Z., Meuillet, E., Zang, S., Lemos, R., Du-Cuny, L., Layng, F. I. A. L., Correa, R. G., Bankston, L. A., Liddington, R. C., Kirkpatrick, L. & Powis, G., Jun 15 2019, In : Cancer Research. 79, 12, p. 3100-3111 12 p.

Research output: Contribution to journalArticle

Growth
Neoplasms
Plastics
Phosphatidylinositol 4,5-Diphosphate
Cell Membrane

Correction: An inhibitor of the pleckstrin homology domain of CNK1 selectively blocks the growth of mutant KRAS cells and tumors (Cancer Research (2019) 79 (3100–3111) DOI: 10.1158/0008-5472.CAN-18-2372)

Indarte, M., Puentes, R., Maruggi, M., Ihle, N. T., Grandjean, G., Scott, M., Ahmed, Z., Meuillet, E. J., Zhang, S., Lemos, R., Du-Cuny, L., Layng, F. I. A. L., Correa, R. G., Bankston, L. A., Liddington, R. C., Kirkpatrick, L. & Powis, G., Oct 15 2019, In : Cancer Research. 79, 20, 1 p.

Research output: Contribution to journalComment/debate

Open Access
Names
Growth
Research
Neoplasms
Emotions
4 Citations (Scopus)

Structural homologies between phenformin, lipitor and gleevec aim the same metabolic oncotarget in leukemia and melanoma

Somlyai, G., Collins, T. Q., Meuillet, E., Hitendra, P., D'Agostino, D. P. & Boros, L. G., 2017, In : Oncotarget. 8, 30, p. 50187-50192 6 p.

Research output: Contribution to journalReview article

Phenformin
Melanoma
Leukemia
Pharmaceutical Preparations
Biguanides
9 Citations (Scopus)

Improved Treatment of Pancreatic Cancer With Drug Delivery Nanoparticles Loaded With a Novel AKT/PDK1 Inhibitor

Kobes, J. E., Daryaei, I., Howison, C. M., Bontrager, J. G., Sirianni, R. W., Meuillet, E. & Pagel, M. M., Feb 26 2016, (Accepted/In press) In : Pancreas.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Nanoparticles
Pharmaceutical Preparations
Diffusion Magnetic Resonance Imaging
Neoplasms
25 Citations (Scopus)

Submolecular regulation of cell transformation by deuterium depleting water exchange reactions in the tricarboxylic acid substrate cycle

Boros, L. G., D'Agostino, D. P., Katz, H. E., Roth, J. P., Meuillet, E. & Somlyai, G., Feb 1 2016, In : Medical Hypotheses. 87, p. 69-74 6 p.

Research output: Contribution to journalArticle

Citric Acid Cycle
Deuterium
Water
Neoplasms
Hydrogen